Allurion Technologies Announces Landmark Clinical Study: Swallowable Smart Capsule Achieves Over 20% Weight Loss, Matching Bariatric Surgery Results
Reuters
Oct 07
<a href="https://laohu8.com/S/ALUR">Allurion Technologies</a> Announces Landmark Clinical Study: Swallowable Smart Capsule Achieves Over 20% Weight Loss, Matching Bariatric Surgery Results
Allurion Technologies Holdings Inc. has announced the publication of a peer-reviewed multicenter study evaluating the consecutive use of the Allurion Smart Capsule, a swallowable, procedure-less weight-loss device. The study, which included participants from six countries, demonstrated that two consecutive treatments with the Smart Capsule resulted in weight loss exceeding 20% of body weight. According to the company, these results are comparable to those achieved with bariatric surgery and high-dose GLP-1 therapy. The study results have already been published and add to the existing data supporting the safety and efficacy of the device. Allurion has also submitted the final module of its Pre-Market Approval (PMA) application to the U.S. Food and Drug Administration (FDA) based on the findings of the AUDACITY trial.
Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Allurion Technologies Holdings Inc. published the original content used to generate this news brief via Business Wire (Ref. ID: 20251007124643) on October 07, 2025, and is solely responsible for the information contained therein.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.